Projected Impact of HCV Treatment on Near-Term Progression of Advanced Liver Disease in HCV-Infected Patients in a High Prevalence Birth Cohort

被引：0
|
作者：
Rubin, Jaime [1 ]
McGarry, Lisa [1 ]
Panchmatia, Hemangi [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
10.14309/00000434-201210001-01433
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1433
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [1] Treatment of HCV-infected patients with advanced kidney disease
    Marco Ladino
    David Roth
    Nature Reviews Nephrology, 2018, 14 : 6 - 8
  • [2] CLINICAL TRIALS Treatment of HCV-infected patients with advanced kidney disease
    Ladino, Marco
    Roth, David
    NATURE REVIEWS NEPHROLOGY, 2018, 14 (01) : 6 - +
  • [3] Similar Progression of Fibrosis Between HIV/HCV-Infected and HCV-Infected Patients: Analysis of Paired Liver Biopsy Samples
    Sterling, Richard K.
    Wegelin, Jacob A.
    Smith, Paula G.
    Stravitz, R. Todd
    Luketic, Velimir A.
    Fuchs, Michael
    Puri, Puneet
    Shiffman, Mitchell L.
    Contos, Melissa A.
    Mills, A. Scott
    Sanyal, Arun J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (12) : 1070 - 1076
  • [4] Aminofeel® improves the sensitivity to taste in patients with HCV-infected liver disease
    Nagao, Yumiko
    Matsuoka, Hisako
    Kawaguchi, Takumi
    Sata, Michio
    MEDICAL SCIENCE MONITOR, 2010, 16 (04): : PI7 - PI12
  • [5] Impact of moderate alcohol consumption on hepatic fibrosis progression in HCV-infected patients
    Barjoan, E. Marine
    Gelsi, E.
    Delasalle, P.
    Ibragimova, N.
    Sattonnet, C.
    Saint-Paul, M. C.
    Gueyffier, C.
    Diebolt, E.
    Hayek, R.
    Fuzibet, J. G.
    Ouzan, D.
    Tran, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S275 - S276
  • [6] High prevalence of antibodies to core+1 /ARF protein in HCV-infected patients with advanced cirrhosis
    Kassela, Katerina
    Karakasiliotis, Ioannis
    Charpantidis, Stefanos
    Koskinas, John
    Mylopoulou, Theodora
    Mimidis, Konstantinos
    Sarrazin, Christoph
    Grammatikos, Georgios
    Mavromara, Penelope
    JOURNAL OF GENERAL VIROLOGY, 2017, 98 (07): : 1713 - 1719
  • [7] THE CLINICAL AND ECONOMIC IMPACT OF HCV TREATMENT ON NON-HEPATIC CANCERS AMONG HCV-INFECTED PATIENTS
    Wang, W.
    Lo Re, V
    Guo, Y.
    Xiao, H.
    Brown, J.
    Park, H.
    VALUE IN HEALTH, 2019, 22 : S36 - S36
  • [8] The prevalence of insulin resistance in HCV-infected patients and its association with treatment outcomes
    Wallace, M.
    Kong, J.
    Nazareth, S.
    Mcinerney, M.
    Tarquinio, L.
    Flexman, J.
    Cheng, W.
    Kontorinis, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A129 - A129
  • [9] Current and Future Disease Progression of HCV-Infected Patients Among Different Age Cohorts
    Zalesak, Martin
    Francis, Kevin
    Kwong, Ann
    Li, Hong
    Martyn, Derek
    Orne, Leslie S.
    Smith, Amanda
    Hvidsten, Kyle
    GASTROENTEROLOGY, 2012, 142 (05) : S965 - S965
  • [10] PHARMACOKINETIC ANALYSES OF LEDIPASVIR/SOFOSBUVIR IN HCV-INFECTED SUBJECTS WITH ADVANCED LIVER DISEASE AND/OR FOLLOWING LIVER TRANSPLANTATION
    Garrison, K. L.
    German, P.
    Arterburn, S.
    De-Oertel, S.
    Brainard, D.
    Ling, J.
    Jin, F.
    Mathias, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S789 - S789
12345